Literature DB >> 8996296

Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.

A F Maes1, M Borgers, W Flameng, J L Nuyts, F van de Werf, J J Ausma, P Sergeant, L A Mortelmans.   

Abstract

OBJECTIVES: The value of 99mTc-sestamibi (2-methoxy-isobutyl isonitrile [MIBI]) as a viability tracer was investigated in patients undergoing coronary artery bypass graft surgery.
BACKGROUND: Initial studies claim that rest MIBI single-photon emission computed tomographic (SPECT) studies can be used to assess myocardial viability.
METHODS: Thirty patients with a severely stenosed left anterior descending coronary artery and wall motion abnormalities were prospectively included. The patients underwent a MIBI rest study, a positron emission tomographic (PET) flow (13NH3) and metabolism (18F-deoxyglucose) study and nuclear angiography before undergoing bypass surgery. A preoperative transmural biopsy specimen was taken from the left ventricular anterior wall. Morphometry was performed to assess percent fibrosis. After 3 months, radionuclide angiography was repeated.
RESULTS: Statistically significant higher MIBI values were found in the group with myocardial viability as assessed by PET than in the group with PET-assessed nonviability (p < 0.01). Significantly higher MIBI values were found in the group with enhanced contractility at 3 months (76 +/- 13% vs. 53 +/- 22%, p < 0.01). A linear relation was found between MIBI uptake and percent fibrosis in the biopsy specimen (r = 0.78, p < 0.00001). When maximizing the threshold for assessment of viability with MIBI by using functional improvement as the reference standard, a cutoff value of 50% was found, with positive and negative predictive values of 82% and 78%, respectively.
CONCLUSIONS: 99mTc MIBI uptake was significantly higher in PET-assessed viable areas and in regions with enhanced contractility at 3 months. A linear relation was found between percent fibrosis and MIBI uptake. An optimal threshold of 50% was found for prediction of functional recovery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996296     DOI: 10.1016/s0735-1097(96)00442-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  29 in total

1.  Use of myocardial perfusion imaging to assess viability.

Authors:  M I Travin
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 3.  Quantification of SPECT myocardial perfusion imaging.

Authors:  Wanda Acampa; Wei He; Carmine di Nuzzo; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

Review 4.  The historical and conceptual evolution of radionuclide assessment of myocardial viability.

Authors:  James E Udelson; Robert O Bonow; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

Review 5.  Nuclear Image-Guided Approaches for Cardiac Resynchronization Therapy (CRT).

Authors:  Weihua Zhou; Ernest V Garcia
Journal:  Curr Cardiol Rep       Date:  2016-01       Impact factor: 2.931

Review 6.  Imaging techniques in nuclear cardiology for the assessment of myocardial viability.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A J O Dierckx; Pieter L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

7.  Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used?

Authors:  Z X He; M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

8.  Myocardial viability: seeking relevance and redefinition.

Authors:  J A Arrighi; R Soufer
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

9.  Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.

Authors:  Riemer H J A Slart; Jeroen J Bax; Wim J Sluiter; Dirk J van Veldhuisen; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

10.  Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.

Authors:  Ankur Gupta; Meagan Harrington; Christine M Albert; Navkaranbir S Bajaj; Jon Hainer; Victoria Morgan; Courtney F Bibbo; Paco E Bravo; Michael T Osborne; Sharmila Dorbala; Ron Blankstein; Viviany R Taqueti; Deepak L Bhatt; William G Stevenson; Marcelo F Di Carli
Journal:  JACC Clin Electrophysiol       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.